Amgen USA Inc. is the U.S. arm of Amgen, a large biotechnology company that develops and sells prescription medicines. It lobbies on pharmacy and drug-pricing rules, including how the Inflation Reduction Act is put into practice and an executive order on drug pricing; on intellectual property and patent laws that affect drugs; and on trade and tariff policies.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
HAZEN CLAY MARSHALL
The latest disclosures for this client.
MARSHALL & POPP, LLC
Q2MARSHALL & POPP, LLC
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
MARSHALL & POPP, LLC
MONICA POPP
MARSHALL & POPP, LLC
MARSHALL & POPP, LLC
Q4MARSHALL & POPP, LLC
Q3MARSHALL & POPP, LLC
Q2MARSHALL & POPP, LLC
Q1